Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Lubbock
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lubbock, TX

Studies commonly pay $75 to $4,500 per completed study

107 clinical trials are currently recruiting participants within 30 miles of Lubbock. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

107studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lubbock right now

Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Peripheral Arterial Disease, Atherosclerosis of Extremities Phase 3 Interventional 6,150 participants sought
Texas Tech University Health Sciences — Lubbock, Texas (2.1 mi) · Sponsor: Population Health Research Institute

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Lubbock, Texas (2.1 mi) · Sponsor: Ambros Therapeutics, Inc.

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi) · Sponsor: SWOG Cancer Research Network

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Phase 3 Interventional 1,350 participants sought
89bio Clinical Study Site — Lubbock, Texas (2.1 mi) · Sponsor: Hoffmann-La Roche

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Pfizer

Annatto-derived GG for Statin-associated Myopathy

Myopathy; Primary Phase 1, Phase 2 Interventional 95 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University Health Sciences Center

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Crohn's Disease Phase 3 Interventional 1,200 participants sought
GI Alliance - Lubbock ( Site 5012) — Lubbock, Texas (2.1 mi) · Sponsor: Merck Sharp & Dohme LLC

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase 3 Interventional 231 participants sought
Site Number - 1048 — Lubbock, Texas (2.1 mi) · Sponsor: Immunovant Sciences GmbH

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi) · Sponsor: Jaeb Center for Health Research

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Lubbock, Texas (2.1 mi) · Sponsor: TG Therapeutics, Inc.

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group

Snacks and Brain Health

Cognitive Assessment, Psychological Function Phase 1, Phase 2 Interventional 60 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University Health Sciences Center

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Acute Ischemic Stroke Phase 3 Interventional 404 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi) · Sponsor: Mercy Health Ohio

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis Phase 3 Interventional 980 participants sought
Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092 — Lubbock, Texas (2.1 mi) · Sponsor: Sanofi

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Non-squamous Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: AstraZeneca

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Arthritis, Psoriatic Phase 3 Interventional 600 participants sought
Clinical Site — Lubbock, Texas (2.1 mi) · Sponsor: MoonLake Immunotherapeutics AG

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Relapsed/Refractory Multiple Myeloma (RRMM) Phase 4 Interventional 30 participants sought
Texas Tech University Health Science Center School of Medicine — Lubbock, Texas (2.1 mi) · Sponsor: Regeneron Pharmaceuticals

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Stroke, Intracranial Atherosclerotic Stenosis (ICAS) N/A Observational 300 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi) · Sponsor: Yale University
Actively enrolling

Studies you may be able to join near Lubbock

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Lubbock

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Texas Tech Physicians Internal Medicine Clinic

★ 4.9
3601 4th St, Lubbock, TX 79430
(806) 743-3150
"Dr Test is one of the nicest, most personable doctors that i have met in a long time."
— Rena Mashburn, 5★

Department of Internal Medicine Texas Tech University Health Sciences Center

★ 3.7
3601 4th St, Lubbock, TX 79430
(806) 743-3155
"If you don't see the little sign behind a large pillar that denotes where the line starts, and innocently stand in the wrong place, the much older, r…"
— Dan Hammons, 1★

Texas Tech University Health Sciences Center

Lubbock, TX 79415

Texas Tech Physicians: Dermatology

★ 4.9
Texas Tech University, Physicians Medical Pavilion, 3601 4th St 4th Floor, Lubbock, TX 79430
(806) 743-1842
"Dr. Alba Posligua, M.D., in the Texas Tech Physicians Dermatology Clinic provides ***EXCEPTIONAL*** quality care.<br><br>All of the staff were extrem…"
— Kelvin Meeks, 5★

Clinical trials in Lubbock: what's recruiting

The Lubbock area currently has 107 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lubbock, the most active research areas are:

  • Cancer & Oncology10 studies
  • Immune & Skin3 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Lubbock, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lubbock

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lubbock participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Lubbock?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Lubbock, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lubbock?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lubbock?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lubbock.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lubbock typically complete one or two studies per year.

Paid clinical trials near Lubbock

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of TX

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts